-sparing , meaning it avoids many common side effects like weight gain and fluid retention. Core Pharmacology and Mechanism
Research has expanded beyond diabetes to several age-related and neurodegenerative conditions: 1. Parkinson’s Disease (PD)
It blocks the entry of pyruvate into the mitochondria, the main gateway for carbohydrate metabolism.
MSDC-0160 is a novel, clinical-stage drug candidate originally developed for . It is the prototype of a new class of insulin sensitizers called mTOT Modulators (Mitochondrial Target of Thiazolidinediones). Unlike first-generation insulin sensitizers like pioglitazone, MSDC-0160 is PPAR
It helps cells maintain "trash removal" systems (autophagy), preventing the toxic buildup of proteins like -synuclein .
By modulating mitochondrial metabolism, it prevents the over-activation of mTOR , a key nutrient sensor that, when overactive, is linked to neurodegeneration and inflammation. 🧠 Therapeutic Applications
In preclinical models, MSDC-0160 protected dopaminergic neurons, improved motor function, and reduced neuroinflammation.
-sparing , meaning it avoids many common side effects like weight gain and fluid retention. Core Pharmacology and Mechanism
Research has expanded beyond diabetes to several age-related and neurodegenerative conditions: 1. Parkinson’s Disease (PD) msdc 0160 buy
It blocks the entry of pyruvate into the mitochondria, the main gateway for carbohydrate metabolism. -sparing , meaning it avoids many common side
MSDC-0160 is a novel, clinical-stage drug candidate originally developed for . It is the prototype of a new class of insulin sensitizers called mTOT Modulators (Mitochondrial Target of Thiazolidinediones). Unlike first-generation insulin sensitizers like pioglitazone, MSDC-0160 is PPAR By modulating mitochondrial metabolism
It helps cells maintain "trash removal" systems (autophagy), preventing the toxic buildup of proteins like -synuclein .
By modulating mitochondrial metabolism, it prevents the over-activation of mTOR , a key nutrient sensor that, when overactive, is linked to neurodegeneration and inflammation. 🧠 Therapeutic Applications
In preclinical models, MSDC-0160 protected dopaminergic neurons, improved motor function, and reduced neuroinflammation.